Thus, genetic or pharmacological activation of TRPV1 may increase Ca2+ influx, reduce APP processing, and consequently improve synaptic plasticity and memory in APP23/PS45 model mice of AD. The gene discussed is TRPV1; the disease is Alzheimer disease.